Overview
Revenue
Non-Applicable per year
Cambridge Cognition Plc (AIM: COG) is an international digital neuroscience company developing and marketing validated software technologies to enhance research into brain health, optimise R&D productivity and precisely quantify cognition in patients worldwide. Our cognitive assessment technologies for mobile, wearable, and online platforms accelerate the development of new treatments, maximise efficiency and data quality throughout research, and improve health outcomes. Our digital health products have been used for over 30 years in thousands of academic and industry clinical trials by the world's leading pharmaceutical and biotech companies, academic institutions and health organisations. Cognitive assessment software for clinical trials, academic research and healthcare Cambridge Cognition Ltd. provides computerized neuropsychological tests for the early detection of dementia. The company offers Cambridge neuropsychological test automated battery (CANTAB) tests in various categories, including induction, visual memory, executive function, attention, semantic/verbal memory, decision making and response control, social cognition, and other tests. It also provides CANTAB eLearning, an online training tool to facilitate remote training for CANTAB eclipse; CANTABmobile, a new touch screen test that enables GPs/healthcare professionals for the early detection and diagnosis of dementia; and CANTAB HAL software, a touch screen technology for the administration and .
